Trial Profile
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2021
Price :
$35
*
At a glance
- Drugs Gentamicin (Primary) ; Antibacterials
- Indications Diabetic foot ulcer; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- Acronyms COACT-2
- Sponsors Innocoll
- 22 Mar 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 03 Nov 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2017 This trial has been completed in Belgium.